The association between KRAS (KRAS Proto-Oncogene, GTPase) and Juvenile Myelomonocytic Leukemia is well established and manually curated, with its 4 contributing sources — 3 of them expert-curated — recording pathogenic variants and causative variation.
Sources4
Clinical variants5
Symptoms4
Compounds0
Trials0
Publications23
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.